Nevertheless, PD-L1 blockade combined with an oncolytic vaccinia virus expressing CXCL11 in murine tumor models was shown to significantly reduce tumor burden and improve prognosis (Jonas, 2017). This evidence concerns the gene CXCL11 and neoplasm.